Capital Bank & Trust CO Gilead Sciences, Inc. Transaction History

Capital Bank & Trust CO

$0
Q3 2022

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $58.9 Million - $63.5 Million	-869,698 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $231,094 - $252,503	3,641 Added 0.42%	869,698 $59.9 Million
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $3.19 Million - $3.64 Million	53,140 Added 6.54%	866,057 $56 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $3.57 Million - $4.07 Million	-63,043 Reduced 7.2%	812,917 $47.4 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $1.74 Million - $2.19 Million	-28,087 Reduced 3.11%	875,960 $55.4 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $2.49 Million - $2.89 Million	34,439 Added 3.96%	904,047 $69.6 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $3.67 Million - $4.7 Million	58,569 Added 7.22%	869,608 $65 Million
Q4 2019 Feb 18, 2020	SELL	$61.62 - $67.78 $2.07 Million - $2.28 Million	-33,584 Reduced 3.98%	811,039 $52.7 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $5.53 Million - $6.11 Million	-88,537 Reduced 9.49%	844,623 $53.5 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $219,700 - $246,368	-3,551 Reduced 0.38%	933,160 $63 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $13.2 Million - $14.8 Million	-211,514 Reduced 18.42%	936,711 $60.8 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $12.8 Million - $16.7 Million	-210,795 Reduced 15.51%	1,148,225 $71.8 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $1.36 Million - $1.51 Million	-19,099 Reduced 1.39%	1,359,020 $105 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $10.6 Million - $12.4 Million	163,196 Added 13.43%	1,378,119 $97.6 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $3.87 Million - $4.72 Million	53,179 Added 4.58%	1,214,923 $91.6 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $2.56 Million - $3.01 Million	-35,984 Reduced 3.0%	1,161,744 $83.2 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $46.4 Million - $55 Million	643,218 Added 116.0%	1,197,728 $97 Million
Q2 2017 Aug 14, 2017	BUY	N/A	554,510	554,510 $39.2 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Capital Bank & Trust CO with notifications on news.

Account